Lectins offer new perspectives in the development of macrophage-targeted therapies for COPD/emphysema.
We have previously shown that the defective ability of alveolar macrophages (AM) to phagocytose apoptotic cells ('efferocytosis') in chronic obstructive pulmonary disease/emphysema (COPD) could be therapeutically improved using the C-type lectin, mannose binding lectin (MBL), although the...
Guardado en:
Autores principales: | Violet R Mukaro, Johan Bylund, Greg Hodge, Mark Holmes, Hubertus Jersmann, Paul N Reynolds, Sandra Hodge |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/58442b7977224fb8ac2766c1c3df0349 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Defective lung macrophage function in lung cancer ± chronic obstructive pulmonary disease (COPD/emphysema)-mediated by cancer cell production of PGE2?
por: Francis C Dehle, et al.
Publicado: (2013) -
The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD
por: Miranda P. Ween, et al.
Publicado: (2021) -
Bushfire smoke is pro-inflammatory and suppresses macrophage phagocytic function
por: Rhys Hamon, et al.
Publicado: (2018) -
Inhibition of LC3-associated phagocytosis in COPD and in response to cigarette smoke
por: Patrick F. Asare, et al.
Publicado: (2021) -
Radiofrequency therapy improves exercise capacity of mice with emphysema
por: Mai Tsutsui, et al.
Publicado: (2021)